Marburg and Ebola Virus mRNA 3' Untranslated Regions Contain Negative Regulators of Translation That Are Modulated by ADAR1 Editing.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
09 09 2021
Historique:
pubmed: 5 8 2021
medline: 12 10 2021
entrez: 4 8 2021
Statut: ppublish

Résumé

The filovirus family includes deadly pathogens such as Ebola virus (EBOV) and Marburg virus (MARV). A substantial portion of filovirus genomes encode 5' and 3' untranslated regions (UTRs) of viral mRNAs. Select viral genomic RNA sequences corresponding to 3' UTRs are prone to editing by adenosine deaminase acting on RNA 1 (ADAR1). A reporter mRNA approach, in which different 5' or 3' UTRs were inserted into luciferase-encoding mRNAs, demonstrates that MARV 3' UTRs yield different levels of reporter gene expression, suggesting modulation of translation. The modulation occurs in cells unable to produce microRNAs (miRNAs) and can be recapitulated in a MARV minigenome assay. Deletion mutants identified negative regulatory regions at the ends of the MARV nucleoprotein (NP) and large protein (L) 3' UTRs. Apparent ADAR1 editing mutants were previously identified within the MARV NP 3' UTR. Introduction of these changes into the MARV nucleoprotein (NP) 3' UTR or deletion of the region targeted for editing enhances translation, as indicated by reporter assays and polysome analysis. In addition, the parental NP 3' UTR, but not the edited or deletion mutant NP 3' UTRs, induces a type I interferon (IFN) response upon transfection into cells. Because some EBOV isolates from the West Africa outbreak exhibited ADAR1 editing of the viral protein of 40 kDa (VP40) 3' UTR, VP40 3' UTRs with parental and edited sequences were similarly assayed. The EBOV VP40 3' UTR edits also enhanced translation, but neither the wild-type nor the edited 3' UTRs induced IFN. These findings implicate filoviral mRNA 3' UTRs as negative regulators of translation that can be inactivated by innate immune responses that induce ADAR1.

Identifiants

pubmed: 34346762
doi: 10.1128/JVI.00652-21
pmc: PMC8428382
doi:

Substances chimiques

3' Untranslated Regions 0
Interferon Type I 0
MicroRNAs 0
Nucleocapsid Proteins 0
RNA, Messenger 0
RNA-Binding Proteins 0
VP40 protein, virus 0
Viral Matrix Proteins 0
nucleoprotein, Marburg virus 145717-56-2
ADAR protein, human EC 3.5.4.37
Adenosine Deaminase EC 3.5.4.4

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0065221

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI120943
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI148663
Pays : United States
Organisme : HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : AI148663
Organisme : HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : AI120943

Références

mBio. 2014 Nov 04;5(6):e02011
pubmed: 25370495
Antiviral Res. 2018 Oct;158:288-302
pubmed: 30144461
Antiviral Res. 2018 Feb;150:193-201
pubmed: 29294299
Nat Struct Mol Biol. 2014 Aug;21(8):671-8
pubmed: 25026077
Cell. 2018 Mar 22;173(1):20-51
pubmed: 29570994
Nature. 2015 Aug 6;524(7563):93-6
pubmed: 25970247
Exp Hematol. 2016 Oct;44(10):947-63
pubmed: 27373493
Cell Rep. 2018 Jan 30;22(5):1159-1168
pubmed: 29386105
Virology. 1996 Sep 15;223(2):376-80
pubmed: 8806574
Mol Cell Biol. 1996 Jan;16(1):146-56
pubmed: 8524291
PLoS One. 2012;7(3):e32661
pubmed: 22438882
Algorithms Mol Biol. 2011 Nov 24;6:26
pubmed: 22115189
Genome Res. 2009 Jan;19(1):92-105
pubmed: 18955434
Cell Rep. 2020 Aug 18;32(7):108028
pubmed: 32814037
RNA. 2014 Jun;20(6):923-37
pubmed: 24757167
Cell Rep. 2016 Feb 23;14(7):1632-1640
pubmed: 26876165
Nat Microbiol. 2016 Sep 05;1(11):16151
pubmed: 27595345
Nat Genet. 2012 Nov;44(11):1243-8
pubmed: 23001123
Methods Enzymol. 2013;530:183-92
pubmed: 24034322
Microbiol Spectr. 2016 Jun;4(3):
pubmed: 27337474
Nucleic Acids Res. 2012 Mar;40(6):2724-33
pubmed: 22127865
Nat Rev Microbiol. 2015 Nov;13(11):663-76
pubmed: 26439085
Nature. 2017 Jul 6;547(7661):114-117
pubmed: 28658212
Cell Rep. 2014 Nov 20;9(4):1482-94
pubmed: 25456137
Curr Top Microbiol Immunol. 2012;353:163-95
pubmed: 21809195
PLoS Pathog. 2013 Jan;9(1):e1003147
pubmed: 23382680
Cell. 2015 Jun 18;161(7):1516-26
pubmed: 26091036
Nature. 2009 Apr 30;458(7242):1185-90
pubmed: 19322177
Front Genet. 2018 Oct 02;9:439
pubmed: 30333857
Front Mol Biosci. 2017 Oct 23;4:71
pubmed: 29109951
Future Virol. 2007 Mar;2(2):205-215
pubmed: 24093048
Curr Top Microbiol Immunol. 2013;371:201-27
pubmed: 23686237
Nature. 2017 Apr 20;544(7650):309-315
pubmed: 28405027
Immunity. 2015 Nov 17;43(5):933-44
pubmed: 26588779
J Virol. 2014 Nov;88(21):12703-14
pubmed: 25142608
Semin Pediatr Infect Dis. 2005 Jul;16(3):219-24
pubmed: 16044395
PLoS Genet. 2020 Feb 3;16(2):e1008285
pubmed: 32012152
Genome Res. 2004 Jun;14(6):1188-90
pubmed: 15173120
Trends Mol Med. 2017 Jan;23(1):80-93
pubmed: 27989642
J Virol. 2002 Sep;76(17):8532-9
pubmed: 12163572
J Virol. 2011 Apr;85(8):3905-17
pubmed: 21289122
PLoS One. 2017 Jun 21;12(6):e0178717
pubmed: 28636653
J Biol Chem. 2009 Oct 23;284(43):29350-6
pubmed: 19710021
J Virol. 2012 Apr;86(7):3787-94
pubmed: 22278222
Database (Oxford). 2014 Nov 07;2014:
pubmed: 25380780
Emerg Infect Dis. 2015 Jul;21(7):1135-43
pubmed: 26079255
Science. 2015 Sep 4;349(6252):1115-20
pubmed: 26275108
Biosaf Health. 2019 Jun;1(1):14-24
pubmed: 32835207
Cell. 2018 Feb 8;172(4):797-810.e13
pubmed: 29395326
Genomics Proteomics Bioinformatics. 2009 Dec;7(4):147-54
pubmed: 20172487
Virology. 2010 Jan 20;396(2):316-22
pubmed: 19913273
Euro Surveill. 2015;20(40):
pubmed: 26539753
Cell. 2018 Feb 8;172(4):811-824.e14
pubmed: 29395325

Auteurs

Sudip Khadka (S)

Center for Microbial Pathogenesis, Institute for Biomedical Sciences, Georgia State Universitygrid.256304.6, Atlanta, Georgia, USA.

Caroline G Williams (CG)

Center for Microbial Pathogenesis, Institute for Biomedical Sciences, Georgia State Universitygrid.256304.6, Atlanta, Georgia, USA.

Joyce Sweeney-Gibbons (J)

Center for Microbial Pathogenesis, Institute for Biomedical Sciences, Georgia State Universitygrid.256304.6, Atlanta, Georgia, USA.

Christopher F Basler (CF)

Center for Microbial Pathogenesis, Institute for Biomedical Sciences, Georgia State Universitygrid.256304.6, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH